ADRIANA TIBBITTS is a partner and a member of the firm’s Global Life Sciences team. Adriana works with clients in the life sciences industry on a broad range of transactional matters, including collaboration and license agreements, co-promotion and other commercialization agreements, joint ventures, M&A, financing transactions, including royalty financing, and the acquisition of pharmaceutical royalty streams. She also represents clients on general corporate and commercial matters. Clients consult Adriana for her experience with technologies that have been the subject of significant interest within the life sciences industry over the past five years, including cell and gene therapies and digital health.
Adriana represents the full spectrum of life sciences clients, including privately held and publicly traded pharmaceutical, biotechnology, and medical device companies at all stages of development as well as universities, academic medical centers, private equity and venture capital funds, and their portfolio companies. She regularly works with inventors and entrepreneurs and a significant portion of her practice is dedicated to supporting formation, financing, licensing and development activities for emerging companies with novel technologies. Adriana also has experience helping clinical-stage companies prepare for commercialization, including expanding their global footprint and helping them engage commercialization partners. She also regularly handles cross-border matters, including transactions in China.
Prior to joining Sidley, Adriana was a partner at another global law firm. Before attending law school, Adriana traveled across the United States as a trial clerk with the U.S. Tax Court.
- Healthcare: Life Sciences (Next Generation Partner), Legal 500 US, 2019-2020